title: [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
abstract: Intractable ascites is a rare complication after liver transplantation. In this study, the authors report 2 cases of intractable ascites after liver transplantation. The authors discuss the etiology of ascites and the place of peritoneovenous shunt as a therapeutic option. From 1985 to 1996, 354 liver transplantations were performed. In two cases, liver transplantation was performed for post-VHC liver cirrhosis and giant hemangioma. Both patients developed intractable ascites and were successfully treated by peritoneovenous shunt. The etiologies of ascites after liver transplantations are multiple: mechanical after vascular complication; lymphatic leak after surgical dissection; metabolic disorder; intrahepatic lesion of the graft. In our cases, the etiology of ascites was intrahepatic lesion of the graft due to VHC infection in the first case and acute rejection in the second. Peritoneovenous shunt is a therapeutic option for the treatment of intractable ascites after liver transplantation. Its indication should be considered only for isolated intractable ascites without portal hypertension and without liver cell failure after liver transplantation.
authors.affiliation: Service de Chirurgie Digestive et de Transplantation Hépatique, Hôpital de la Croix-Rousse, Lyon.
authors.forename: J Y
authors.initials: JY
authors.lastname: Mabrut
authors.forename: E
authors.initials: E
authors.lastname: de la Roche
authors.forename: M
authors.initials: M
authors.lastname: Adham
authors.forename: C
authors.initials: C
authors.lastname: Ducerf
authors.forename: J
authors.initials: J
authors.lastname: Baulieux
mesh_terms: D000208:Acute Disease; D000328:Adult; D000714:Anastomosis, Surgical / Q000009:adverse effects; D001201:Ascites / Q000209:etiology / Q000601:surgery* / Q000821:virology; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000150:complications; D006391:Hemangioma / Q000601:surgery; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery / Q000821:virology; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects*; D008196:Lymph; D008297:Male; D008875:Middle Aged; D010536:Peritoneovenous Shunt; D012008:Recurrence; D013927:Thrombosis / Q000209:etiology; D014682:Vena Cava, Inferior